307 related articles for article (PubMed ID: 23202368)
1. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
Shami A; Gustafsson R; Kalamajski S; Krams R; Segers D; Rauch U; Roos G; Nilsson J; Oldberg Å; Hultgårdh-Nilsson A
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):354-61. PubMed ID: 23202368
[TBL] [Abstract][Full Text] [Related]
2. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
3. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
Rahaman SO; Li W; Silverstein RL
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
[TBL] [Abstract][Full Text] [Related]
4. The role of platelet-endothelial cell adhesion molecule-1 in atheroma formation varies depending on the site-specific hemodynamic environment.
Harrison M; Smith E; Ross E; Krams R; Segers D; Buckley CD; Nash GB; Rainger GE
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):694-701. PubMed ID: 23372062
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.
Madhur MS; Funt SA; Li L; Vinh A; Chen W; Lob HE; Iwakura Y; Blinder Y; Rahman A; Quyyumi AA; Harrison DG
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1565-72. PubMed ID: 21474820
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821
[TBL] [Abstract][Full Text] [Related]
8. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
10. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
[TBL] [Abstract][Full Text] [Related]
12. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism.
McGraw AP; Bagley J; Chen WS; Galayda C; Nickerson H; Armani A; Caprio M; Carmeliet P; Jaffe IZ
J Am Heart Assoc; 2013 Feb; 2(1):e000018. PubMed ID: 23525413
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of experimental atherosclerosis by interleukin-19.
Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice.
Pulakazhi Venu VK; Uboldi P; Dhyani A; Patrini A; Baetta R; Ferri N; Corsini A; Muro AF; Catapano AL; Norata GD
Thromb Haemost; 2015 Jul; 114(1):186-97. PubMed ID: 25881051
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
19. Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis.
Shen J; Chandrasekharan UM; Ashraf MZ; Long E; Morton RE; Liu Y; Smith JD; DiCorleto PE
Circ Res; 2010 Mar; 106(5):902-10. PubMed ID: 20093631
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.
Theelen TL; Lappalainen JP; Sluimer JC; Gurzeler E; Cleutjens JP; Gijbels MJ; Biessen EA; Daemen MJ; Alitalo K; Ylä-Herttuala S
Atherosclerosis; 2015 Aug; 241(2):297-304. PubMed ID: 26062989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
